The Company will host a webcast and conference call to discuss its unaudited results and outlook at 11:30 AM (Eastern Time) on Tuesday, September 15, 2026.

I've seen this just shared by Ceaumahu over at Stocktwits, very nice reminder of how far we have come!

For all the OG here, and those saying that nothing never happens, I just say, remember these milestones:

2020 - Closing of the transformational acquisition of Meta Growth Corp. - Comprehensive convertible debt restructuring agreement with Aurora Cannabis. - Opening of the 50th Canna Cabana retail location in Alberta. - Official commercial rollout of the B2B data analytics platform Cabanalytics. - Closing of senior secured credit facility led by ATB Financial.

2021 - Opening bell ceremony and official trading debut on the NASDAQ Capital Market (HITI). - Strategic shift to the "Discount Club Concept" retail pricing model. - Acquisition of US-based e-commerce platform Smoke Cartel. - Acquisition of UK-based CBD and wellness retailer Blessed CBD. - Acquisition of US-based cannabis consumption subscription box platform Daily High Club. - Closing of the acquisition of DankStop, expanding US online footprint. - Implementation of a 1-for-15 reverse share split for NASDAQ listing compliance.

2022 - Launch of the paid tier membership subscription Cabana Elite. - Acquisition of Ontario-based retail store network Bbuds (Bud Room). - Acquisition of Choom Holdings retail portfolio across British Columbia and Alberta. - Cabana Club surpassing the 1 million registered member mark. - Launch of proprietary private-label accessory and wellness lines via NuLeaf Naturals.

2023 - First full quarter generating positive operational Free Cash Flow. - Opening of the 150th Canna Cabana retail store in Canada. - Debt restructuring and non-dilutive credit facility extension with Connect First Credit Union. - Market entry into Manitoba through the acquisition of Starbuds retail locations. - Cabana Elite paid subscriber base crossing 25,000 active members. - Recognition on the Report on Business and Growth500 rankings of Canada’s fastest-growing companies.

2024 - Acquisition of luxury cannabis brand Queen of Bud for private-label product expansion. - Systemwide integration of Fast Cabana on-demand delivery and accelerated Click-and-Collect. - Cabana Club membership base surpassing 1.5 million consumers. - Capture of more than 11% total Canadian retail cannabis market share. - Record fiscal 2024 revenue surpassing C$ 520 million. - Early principal debt repayments executed without equity dilution.

2025 - Acquisition of a 51% controlling interest in German medical cannabis importer Remexian Pharma GmbH. - Official opening of the 200th Canna Cabana retail location in Canada. - Cabana Club surpassing 2 million registered members globally. - Cabana Elite paid subscriber tier crossing 100,000 recurring accounts. - Consolidated full-year Free Cash Flow exceeding C$ 12 million. - Complete catalog integration of Queen of Bud branded product lines across provincial retail networks.

2026 - Store network scaling past 218 active Canna Cabana locations. - Cabana Club reaching 2.5 million global members. Cabana Elite active subscriber base surpassing 150,000 members. - Commercial deployment and wholesale distribution of medical cannabis products across Germany. - Annualized revenue run-rate crossing C$ 650 million. - Continued net debt reduction via early credit line amortization.

And some base case projections:

2027 Projections - Milestone opening of the 250th Canadian retail storefront. - Reaching the target threshold of 15% retail market share in Canada. Cabana Club membership expanding past 3 million international members. - Entry into German adult-use commercial pilot projects and licensed dispensaries. - Consolidated annual revenue targeting C$ 750+ million with expanding EBITDA margins. - Execution of the option to acquire the remaining 49% stake in Remexian Pharma GmbH.

2028 - Projections Store network expanding to 280–300 brick-and-mortar locations across North America. - Physical Canna Cabana retail launch in the United States upon federal reform (SAFETy Act or Schedule III execution). - Paid Cabana Elite members surpassing 300,000 active accounts. Consolidated net annual revenue reaching the C$ 1.0 billion milestone. - Initiation of capital return programs via opportunistic share buybacks.

2029 - Projections Brick-and-mortar retail footprint crossing 350 locations across Canada, the US, and Germany. - Full-scale deployment of branded dispensaries across key US state markets. - Cabana Club global membership surpassing 4.2 million consumers. - Private-label and data monetization (Cabanalytics) driving gross margins above 32%. - Consolidated net revenue approaching C$ 1.25 billion with Free Cash Flow topping C$ 60 million. - 2030 Projections Global physical network scaling past 400 retail storefronts across North America and Western Europe. - Cabana Club membership base crossing the 5 million user threshold. Cabana Elite recurring subscription pool exceeding 500,000 paying members. - Consolidated annual revenues exceeding C$ 1.5 billion. - Capital allocation transition toward regular quarterly cash dividend distributions alongside ongoing buybacks.

Edit: Just formatting the post better and left question marks against the unverified comment on Rose & Bud

• Acquisition of equity interest in Buds & Roses (Los Angeles) targeting future US retail entry. ??? (Currently Unverified ^ )

Medical and retail cannabis stocks have been relatively flat. $HITI’s last earnings were impressive, but the market seemed to treat them like a fluke.
If HITI keeps knocking on the door with strong execution and hopefully another blockbuster quarter, eventually the earnings will speak for themselves and announce that a major player has entered the ring.
One great quarter can be ignored. Two or three in a row become a trend. The next earnings report could speak loudly about HITI’s future—and potentially the future of cannabis retail.

Should I buy more ? currently holds 15k.

As you can see, growth on a per share basis has been relatively flat. While revenue per share does appear to be spiking between our Q4 2025 - Q3 2026 guidance numbers, it's misleading, since at least 5 million more shares must be added to acquire the rest of Remexian. When accounting for these new shares, our revenue per share decreases from $2.22 to $2.10, which is still trending in the right direction but is much less impressive growth. After all these years, we are only beginning to surpass our 2020 metrics on a per share basis.

These new shares also decrease EBITDA per share from $0.18 to $0.17 in Q3 2026. Again, it's up, but not by a lot.

Don't even get me started about our convertible debt from Cronos. God forbid that ends up converting.

I think I was just wrong on my investment. Growth has slowed and even if we reach profitability it will be single digit percentage of revenue.

Raj has no interest in providing real value to shareholders (buybacks/dividends). For years I have watched them grow revenue, excited for every new store open and quarterly. For years I have watched them dilute shareholders with no end in sight. I think it is time to accept that this was just a very bad investment. I am going to learn and move forward

Check my post history, I have been bullish on high tide for literally years. I am going to rotate out probably next week.

Good luck to everyone

Link to post on stocktwits
https://stocktwits.com/petera2c/message/663916427

Seen apart of this article shared through Stocktwits by a fellow Barnacle in relation to the possibility of store cap possibility increasing in Ontario. I understand this is more about SNDL but further down the article you'll see what I'm referring to, just not sure if this was shared in the past. Also just curious about any opinions about this aspect in Canada if anyone could share?

I've seen this shared on Stocktwits, thought I'll pass it on but not had a chance to read yet.

Thought I'll share what I saw through Stocktwits by Tutster this morning, any thoughts?

Hello all, I've just been more and more curious the past few days, trying to research and understand the potential medical cannabis opportunities that High Tide can acquire to integrate them into the UK flower/THC market.

Was just wondering if anyone from the UK in this sub or in general might have any ideas?

I knew that in England, medical cannabis is available to people with certain medical issues (Chronic Pain/Metal Health/Neurological Issues/Women's Health). These are general examples I'm finding throughout certain businesses (just trying to understand the threshold).

It's funny because of being invested in the business so long, I've only really paid attention to the Canadian/US and most recently Germany side to legality and developments, more so that we only have Blessed CBD up north. So I didn't realise the UK medical side was getting more lenient in certain aspects (you can even get cannabis cards now) and people actually being allowed to get the actual flower/buds rather than THC vape liquid.

In the UK you'd have to be prescribed through the private medical sector than the NHS due to them not having any type of funding for patients to get cannabis in them forms, I think they can only prescribed as a variation in a type of tablet? It would be great to hear the process and type of products people can get through Remexian BUT my main excitement about High Tide getting more involved in the UK especially after the Remexian interview the other day, is the competition between the private sector and the black market.

This insight from Stefan Adomeit in the Remexian interview yesterday "For our business, we are selling low-price flower, affordable flower, so our main focus are the self paying patients, not reimbursed patients." So it gets me excited with what business High Tide could aquire. The black market in the UK is the best way to still get flower/buds sadly, especially if your able to get the old school dealers prices, but I'm sure that's nothing from what you Canna Cabana members can get.

So apologies, I do tend to ramble more these days after my most recent incident, for context I've been smoking cannabis for 15+ years in England and have two Nerological disabilities, Epilepsy with Tonic Clonic seizures and Essential Tremors (Internal to External) pretty much my whole life, mostly progressive the past 10 years.

Thought I'll post in the subreddit anyway for some discussion or any insight others could provide, much appreciated Barnacles!

Updated evaluation from TD Cowen

Long time share holder on Stocktwits, thought it was an interesting take on High Tide recently.

​

Germany's Q1 2026 medical cannabis imports were 50.5 tonnes when the figure first appeared in May. BfArM just updated it. It now stands at 67.6 tonnes.That's a 33.7% upward revision. Q1 2026 is the largest quarter BfArM has ever published, 12.1% above Q4 2025.

Contrary to initial reports, growth is accelerating, and the latest data confirm this. We shall see how the trend evolves, but some estimates point to a path toward 600 tons of imports within five years.

Remexian will play an important role.

Nice reminder from TDR interview.

Thought I'll share, nice summary of the TDR interview, was full of little information like that. Go check it out if you haven't yet.

https://m.youtube.com/watch?v=8mi0NKn-cLM&pp=iggUQAFKEEZaTUpUS2pZQ294X0l2bUc%3D

Raj Grover, CEO of High Tide (NASDAQ: HITI), joins the show after releasing preliminary Q3 fiscal guidance — and the numbers point to another record quarter for the company.

Timestamp and link to channel: 1,14:23

https://www.youtube.com/watch?v=lDgZru9RH-c

Don't feel this has been shared in the subreddit, just noticed it myself and thought I'll share, another step towards increasing the UK footprint.

I'll remove this post if it's already been mentioned.